Actively Recruiting
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
Led by MaxWell Clinic, PLC · Updated on 2024-10-18
224
Participants Needed
3
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share the signs and symptoms of long COVID.
CONDITIONS
Official Title
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Mentally capable of understanding and completing informed consent for the study.
- Participants with a lab verified diagnosis of SARS-CoV-2 or clinician note/record that an appropriate rapid test for SARS-CoV-2 was positive.
- Participants must have new, persistent symptoms related to SARS-CoV-2 infection to qualify for the Long COVID group.
- Participants must be 18 years or older.
You will not qualify if you...
- Subject is unable to provide informed consent.
- Investigator determines that ongoing medical complaints after November 1, 2019, are not related to SARS-CoV-2 but another disease process.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University of Iowa
Iowa City, Iowa, United States, 52242
Not Yet Recruiting
2
The MaxWell Clinic
Brentwood, Tennessee, United States, 37027
Actively Recruiting
3
The MaxWell Clinic
Brentwood, Tennessee, United States, 37027
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
14
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here